• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Reply To: Newcomer

International Alliance of ALS/MND Associations › Forums › Member Forum › Newcomer › Reply To: Newcomer

September 29, 2016 at 10:06 pm #2167
Gudjon_Iceland
Participant

    Greetings to you as well my dear friends from Turkey and around the world.

    Primary Sidebar

    • Aida Trzmiel de Guterman, Argentina

      Aida Trzmiel de Guterman, Argentina

    • Torben Mikkelsen, Denmark

      Torben Mikkelsen, Denmark

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Rob Tison, USA

      Rob Tison, USA

    • Shay Rishoni, Israel

      Shay Rishoni, Israel

    • Inta Grubb, Australia

      Inta Grubb, Australia

    • Dawn Morton, Scotland

      Dawn Morton, Scotland

    • Rudiger Hanemann, Germany

      Rudiger Hanemann, Germany

    • Kris Van Reusel, Belgium

      Kris Van Reusel, Belgium

    • Graham Johnson, Australia

      Graham Johnson, Australia

    • Fabio Correia, Brazil

      Fabio Correia, Brazil

    • Den Haag, Netherlands

      Den Haag, Netherlands

    • John Russo, USA

      John Russo, USA
      final3878

    • Yolanda Armendariz, Mexico

      Yolanda Armendariz, Mexico

    • Jorge Luis Fernández Romero, Mexico

      Jorge Luis Fernández Romero, Mexico

    • Wiebke Braach, Germany

      Wiebke Braach, Germany

    • Hans Dieter Olszewski, Germany

      Hans Dieter Olszewski, Germany

    • Imelda Arenas, Colombia

      Imelda Arenas, Colombia

    • Guido De Mets, Belgium

      Guido De Mets, Belgium

    • Luis Antonio Pimenta Lima, Brazil

      Luis Antonio Pimenta Lima, Brazil

    • Mona H. Bahus and Camilla Knoff Glomstad, Norway

      Mona H. Bahus and Camilla Knoff Glomstad, Norway

    • Jon Newsome, USA

      Jon Newsome, USA

    • Lombana, Spain

      Lombana, Spain

    • Orlando Ruiz, Colombia

      Orlando Ruiz, Colombia

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Olga, Argentina

      Olga, Argentina

    • Eric Von Schaumburg, USA

      Eric Von Schaumburg, USA

    • Claudia Gotti, Brazil

      Claudia Gotti, Brazil

    • Andres Estevez Guersznik, Ireland

      Andres Estevez Guersznik, Ireland

    • Ywan Dierick, Belgium

      Ywan Dierick, Belgium

    • Brigitte Wernli, Switzerland

      Brigitte Wernli, Switzerland

    • Mauril Belanger, Canada

      Mauril Belanger, Canada

    • Feng Gin Sun, China

      Feng Gin Sun, China

    • Jan Zuring, Netherlands

      Jan Zuring, Netherlands

    • Zabun Nassar, England

      Zabun Nassar, England

    • Erwin Coppejans, Belgium

      Erwin Coppejans, Belgium

    • Enzo Maccarrone, Italy

      Enzo Maccarrone, Italy

    • Steve Gallagher, Canada

      Steve Gallagher, Canada
      Picture1

    • Angie Bordaen, Belgium

      Angie Bordaen, Belgium

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Osiel Mendoza, USA

      Osiel Mendoza, USA

    • Elkin Gaviria, Colombia

      Elkin Gaviria, Colombia

    • Chris McCauley, Canada

      Chris McCauley, Canada

    • Sam Hayden-Harler, UK

      Sam Hayden-Harler, UK

    • Angelique van der Lit-van Veldhuizen, Netherlands

      Angelique van der Lit-van Veldhuizen, Netherlands

    • Shaleen Latchman, Canada

      Shaleen Latchman, Canada

    • Hollister

      Hollister
      hollister

    • Dr. Janmejay Pradhan, India

      Dr. Janmejay Pradhan, India

    • Anthony Lynch, Australia

      Anthony Lynch, Australia

    • Bjarne Hytjanstorp, Norway

      Bjarne Hytjanstorp, Norway

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login